Skip to content

Collegium Pharmaceutical, Inc. COLL Intangible assets — net

Intangible assets — net at other companies

Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
Avanos Medical logo
Avanos MedicalAVNS
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
Organon logo
OrganonOGN
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD

Segments

By product

See full
Jornay PM$502.97M-14.3%
Belbuca$56.54M-57.1%
Symproic and other$42.5M-14.6%
Symproic$40.68M-15.2%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+17.9%
Enterprise value$869.67M-0.3%
P/E15.4×-6.9×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s intangible assets — net?
Collegium Pharmaceutical, Inc. (COLL) reported intangible assets — net of $614.04M in Q1 2026.